Alexander Nichols
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Alexander Nichols
Alexander Nichols is recorded as COO at enGene Therapeutics Inc. (ENGN). enGene Therapeutics Inc. reported in an 8-K filed October 21, 2024 that Alexander Nichols was appointed Chief Strategy and Operations Officer, effective October 21, 2024. The proxy statement of enGene Therapeutics Inc. reports total compensation of $969,950 for Alexander Nichols in fiscal 2023, including a base salary of $312,500.
“Effective October 21, 2024, Dr. Alexander Nichols’ title and role changed from President and Chief Operating Officer to Chief Strategy and Operations Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-10-21–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at enGene Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Ron Cooper CEO, Board Member
- Ronald H. W. Cooper CEO, Board Member
- Ronald H.W. Cooper CEO, Board Member
- Ryan Daws CFO
- Alex Nichols COO
- Dr. Alex Nichols COO
- Anthony Cheung CTO
- Joan Connolly CTO
- Dr. William Grossman Board Member
- Gerald Brunk Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | enGene Therapeutics Inc. (ENGN) | President and Chief Operating Officer | $312,500 | $969,950 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.